SavedAdd your journal

Journals / Infectious diseases and clinical microbiology (Online) / 2020 / Cilt: 2 - Sayı: 2

Candida Infections: Clinical Features, Diagnosis and Treatment

Sylvain Parfait Bouopda Tamo
Pages
91–102
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review provides an overview of the Candida species involved, clinicalaspects, diagnostic methods, and treatments available against candidiasis encountered inhuman pathology.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Candidiasis is an opportunistic infection caused by yeasts of the genus Candida.
📊
Key Findings & Data:In recentyears, there has been a great deal of interest in Candida infections because of the resurgenceof diseases that weaken the immune system and the widespread use of immunosuppressivechemotherapy.
💡
Conclusion & Impact:This review provides an overview of the Candida species involved, clinicalaspects, diagnostic methods, and treatments available against candidiasis encountered inhuman pathology.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Candidiasis is an opportunistic infection caused by yeasts of the genus Candida. In recentyears, there has been a great deal of interest in Candida infections because of the resurgenceof diseases that weaken the immune system and the widespread use of immunosuppressivechemotherapy. The choice of diagnosis method and identification of the Candida speciesat the origin of the infection is essential for better management of patients, because theinfectious mechanisms and the sensitivity to antifungal agents can vary from one Candidaspecies to another. This review provides an overview of the Candida species involved, clinicalaspects, diagnostic methods, and treatments available against candidiasis encountered inhuman pathology.

🔖

Cite This Article

Tamo, S. P. B. (2022). Candida Infections: Clinical Features, Diagnosis and Treatment. Infectious diseases and clinical microbiology (Online), Cilt: 2 - Sayı: 2, 91–102. https://ajindex.com/articles/539103

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. 1 Bongomin F, Gago S, Oladele R, Denning D. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J Fungi (Basel) 2017
  2. 2 Gupta P, Gautam P, Rai N, Kumar N. An emerging hope to combat Candida albicans: plantbased therapeutics. Biotechnol Int 2012
  3. 3 Calderone RA, Clancy CJ, editors. Candida and Candidiasis. Washington: American Society of Microbiology Press. 2012. 4 Hani U, Hosakote G, Vaghela R, Osmani RA, Shrivastava A. Candidiasis: a fungal infection-current challenges and progress in prevention and treatment. Infect Disord Drug Targets 2015
  4. 5 Berkow EL, Lockhart SR. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist 2017
  5. 6 Han Y, Ulrich M, Cutler J. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J Infect Dis 1999
  6. 7 Cateau E, Rodier MH, Imbert C. Candidoses associées aux cathéters: Quelle place pour les verrous antifongiques? [Could antifungal lock be useful in the management of candiasis linked with catheters ?] Med Sci (Paris) 2012
  7. 8 Madhu P. Oral candidiasis. Int J Pharm Sci Invent 2013
  8. 9 Guessous-Idrissi N, Essari A, Abdallaoui S, Youssouf M. Première identification de Candida dubliniensis au centre hospitalier universitaire Ibn Rochd de Casablanca, Maroc. J Mycol Med 2007
  9. 10 Eggimann P, Que YA, Revelly J P, Pagani JL. Preventing invasive Candida infections. Where could we do better? J Hosp Infect 2015
  10. 11 Seleem D, Pardi V, Mendonça Murata R. Review of flavonoids: a diverse group of natural compounds with anti-Candida albicans activity in vitro. Arch Oral Biol 2017
  11. 12 Allen CM, Saffer A, Meister RK, Beck FM, Bradway S. Comparison of a lesion-inducing isolate and a nonlesional isolate of Candida albicans in an immunosuppressed rat model of oral candidiasis. J Oral Pathol Med 1994
  12. 13 McIlroy M. Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia and typhlitis. J Infect Dis 1991
  13. 14 Marinho S, Teixeira AB, Santos OS, Cazanova RF, Ferreira CA, Cherubini K, de Oliveira SD. Identification of Candida spp. by phenotypic tests and PCR. Braz J Microbiol 2010
  14. 15 Godoy P, Almeida LP, Lopes-Colombo A. Identificación de Candida albicans utilizando el medio cromogénico Albicans ID. Rev Iberoam Micol 2001
  15. 16 Lortholary O, Desnos-Oliver M, Sitbon